Complications of Reduced Intensity Conditioning HSCT for XIAP Deficiency (Alloimmune Cytopenias and HLH) Successfully Managed With Donor Lymphocyte Infusion

J Pediatr Hematol Oncol. 2015 Apr;37(3):e198-9. doi: 10.1097/MPH.0000000000000191.

Abstract

X-linked inhibitor of apoptosis protein deficiency is a rare illness and although stem cell transplant is curative, full intensity conditioning is associated with high mortality rates. We describe a child with unusual complications associated with residual host lymphocytes following reduced intensity stem cell transplant. Recipient derived, donor directed, antigranulocyte antibodies led to life-threatening and prolonged neutropenia and residual recipient lymphocytes reestablished hemophagocytic lymphohistiocytosis after withdrawal of immune suppression despite high levels of whole blood chimerism. Hemophagocytic lymphohistiocytosis was abolished following specific improvement in donor T-cell chimerism after donor lymphocyte infusions, and alloimmune cytopenias were no longer evident.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Combined Modality Therapy
  • Genetic Diseases, X-Linked / complications*
  • Genetic Diseases, X-Linked / pathology
  • Genetic Diseases, X-Linked / therapy*
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / pathology
  • Graft vs Host Disease / prevention & control*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Lymphocytes / cytology*
  • Lymphohistiocytosis, Hemophagocytic / etiology
  • Lymphohistiocytosis, Hemophagocytic / pathology
  • Lymphohistiocytosis, Hemophagocytic / prevention & control
  • Lymphoproliferative Disorders / complications*
  • Lymphoproliferative Disorders / pathology
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Myeloablative Agonists / therapeutic use
  • Pancytopenia / etiology
  • Pancytopenia / pathology
  • Pancytopenia / prevention & control
  • Prognosis
  • Transplantation Chimera
  • Transplantation Conditioning / adverse effects*
  • Transplantation, Homologous
  • X-Linked Inhibitor of Apoptosis Protein / deficiency*
  • X-Linked Inhibitor of Apoptosis Protein / genetics

Substances

  • Myeloablative Agonists
  • X-Linked Inhibitor of Apoptosis Protein
  • XIAP protein, human

Supplementary concepts

  • Lymphoproliferative Syndrome, X-Linked, 2